Zogenix Inc. buy marge
Start price
07.09.18
/
50%
€40.27
Target price
04.11.21
€79.00
Performance (%)
-66.60%
End price
05.11.21
€13.45
Summary
This prediction ended on 05.11.21 with a price of €13.45. Massive losses of -66.60% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Zogenix Inc. | - | - | - | - |
| iShares Core DAX® | -0.383% | 5.021% | 16.188% | 19.224% |
| iShares Nasdaq 100 | 1.248% | 4.007% | 36.579% | 57.508% |
| iShares Nikkei 225® | 0.525% | -0.109% | 12.378% | 9.329% |
| iShares S&P 500 | 0.640% | 3.649% | 28.752% | 47.932% |
Comments by marge for this prediction
In the thread Zogenix Inc. diskutieren
Zogenix mit Aufwärtspotential
Zogenix with positive results from a Phase 2 clinical trial evaluating ZX008 in patients with Lennox-Gastaut syndrome (LGS), a rare and severe type of childhood epilepsy.
Zogenix initiated with Buy rating and $116 (154% upside) price target at B. Riley FBR citing upside for ZX008.
In the thread Trading Zogenix Inc.
Die von marge gewählte maximale Laufzeit wurde überschritten